









Markets
/
Stocks
/
nasdaq-mbx
/

MBX Biosciences Inc

MBX

30.900USD

-1.210-3.77%

Close 12/26, 16:00（ET）Quotes delayed by 15 min

1.38BMarket Cap

LossP/E TTM



MBX Biosciences Inc

30.900

-1.210-3.77%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of MBX Biosciences Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

Total equity

Cash, cash equivalents and short-term investments

41.37%391.67M

306.98%224.91M

242.43%240.79M

--262.15M

--277.06M

--55.26M

--70.32M

- Cash and cash equivalents

67.93%223.13M

218.17%39.78M

-15.59%29.90M

--49.35M

--132.87M

--12.50M

--35.42M

-Short-term investments

16.89%168.55M

332.95%185.13M

504.41%210.88M

--212.80M

--144.20M

--42.76M

--34.89M

Receivables

80.42%1.55M

412.80%841.00K

595.98%1.39M

--682.00K

--858.00K

--164.00K

--199.00K

-Loans receivable

--1.55M

--841.00K

--1.39M

----

-Other receivables

----

--682.00K

--858.00K

--164.00K

--199.00K

Prepaid expenses

40.98%3.40M

-5.17%2.97M

-26.56%1.48M

--3.65M

--2.41M

--3.13M

--2.01M

Other current assets

5.25%882.00K

95.04%472.00K

272.62%626.00K

--803.00K

--838.00K

--242.00K

--168.00K

Total current assets

41.37%397.50M

289.77%229.19M

236.02%244.28M

--267.29M

--281.17M

--58.80M

--72.70M

Non-current assets

Net Fixed Assets

113.90%2.52M

78.34%2.28M

81.82%1.60M

--1.20M

--1.18M

--1.28M

--880.00K

-Fixed Assets

102.98%3.13M

81.19%2.84M

89.78%2.10M

--1.62M

--1.54M

--1.57M

--1.11M

-Accumulated depreciation

67.58%610.00K

93.77%560.00K

120.80%499.00K

--422.00K

--364.00K

--289.00K

--226.00K

Other non-current assets

0.00%50.00K

-98.18%51.00K

-97.13%50.00K

--50.00K

--2.80M

--1.74M

Total non-current assets

109.27%2.57M

-42.86%2.33M

-37.09%1.65M

--1.25M

--1.23M

--4.08M

--2.62M

Total assets

41.67%400.08M

268.18%231.52M

226.51%245.93M

--268.54M

--282.40M

--62.88M

--75.32M

Liabilities

Current liabilities

-Other payables

--0.00

----

Accrued expenses

41.52%8.14M

21.58%5.85M

160.61%6.11M

--5.54M

--5.75M

--4.81M

--2.34M

Other current liabilities

--0.00

----

Total current liabilities

10.46%12.06M

43.40%11.76M

84.01%10.48M

--11.05M

--10.92M

--8.20M

--5.70M

Non-current liabilities

Long-term debt and lease liabilities

965.91%469.00K

488.51%512.00K

-100.00%0.00

--0.00

--44.00K

--87.00K

--129.00K

-Long-term lease liabilities

965.91%469.00K

488.51%512.00K

----

--0.00

--44.00K

--87.00K

--129.00K

Other non-current liabilities

-89.71%7.00K

-88.00%15.00K

-87.57%23.00K

--42.00K

--68.00K

--125.00K

--185.00K

Total non-current liabilities

325.00%476.00K

148.58%527.00K

-92.68%23.00K

--42.00K

--112.00K

--212.00K

--314.00K

Total liabilities

13.65%12.54M

46.05%12.28M

74.78%10.50M

--11.09M

--11.03M

--8.41M

--6.01M

Shareholders' equity

Common equity

50.01%589.80M

6672.03%400.02M

8036.87%396.75M

--394.89M

--393.18M

--5.91M

--4.88M

Preferred equity

----

--152.36M

Retained earnings

-66.02%-202.41M

-74.22%-180.80M

-83.56%-161.38M

---137.50M

---121.92M

---103.78M

---87.92M

Capital reserves

50.01%589.79M

6674.24%400.02M

8038.44%396.75M

--394.89M

--393.18M

--5.91M

--4.88M

Gains losses not affecting retained earnings

45.28%154.00K

173.33%11.00K

1866.67%53.00K

--55.00K

--106.00K

---15.00K

---3.00K

Total equity

42.81%387.54M

302.48%219.24M

239.67%235.42M

--257.44M

--271.37M

--54.47M

--69.31M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

